Literature DB >> 16036167

Challenges in herbal research: a randomized clinical trial to assess blinding with ginger.

Suzanna M Zick1, Amy Blume, Daniel Normolle, Mack Ruffin.   

Abstract

OBJECTIVE: To assess methods to blind study participants to encapsulated ginger (Zingiber officinale).
DESIGN: A randomized double-blind placebo controlled trial.
SUBJECTS: Eighty healthy male and female volunteers. OUTCOME MEASURES: Whether participants can accurately determine if they receive a ginger or placebo capsule and a bottle filled with ginger or placebo capsules.
RESULTS: Forty-two subjects correctly identified the capsule they received. Of those who received placebo, over 82% correctly identified their capsule. Only 22.5% of those who received ginger correctly identified their capsule. The likelihood of guessing ginger between the groups was statistically similar (p<0.01). 65% correctly guessed which bottle they had received (p=0.0073). Participants receiving the bottle filled with ginger capsules successfully identified their bottle 75% of the time (p=0.0016) compared to the 55% of the placebo group (p=0.5).
CONCLUSIONS: Volunteers cannot determine which type of individual capsule they receive but can distinguish a bottle filled with ginger capsules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16036167     DOI: 10.1016/j.ctim.2005.04.001

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  3 in total

1.  A pre-trial evaluation of blinding for a Chinese herbal medicine trial.

Authors:  Shohreh Razavy; John Lee; Christopher Zaslawski
Journal:  Contemp Clin Trials Commun       Date:  2020-08-05

2.  Unique aspects of herbal whole system research.

Authors:  Suzanna M Zick; Herbert Schwabl; Andrew Flower; Bibhas Chakraborty; Kristine Hirschkorn
Journal:  Explore (NY)       Date:  2009 Mar-Apr       Impact factor: 1.775

Review 3.  Efficacy of Oral Ginger (Zingiber officinale) for Dysmenorrhea: A Systematic Review and Meta-Analysis.

Authors:  Chen X Chen; Bruce Barrett; Kristine L Kwekkeboom
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-05       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.